1. Home
  2. NX vs IOVA Comparison

NX vs IOVA Comparison

Compare NX & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NX
  • IOVA
  • Stock Information
  • Founded
  • NX 1927
  • IOVA 2007
  • Country
  • NX United States
  • IOVA United States
  • Employees
  • NX N/A
  • IOVA N/A
  • Industry
  • NX Metal Fabrications
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NX Industrials
  • IOVA Health Care
  • Exchange
  • NX Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • NX 852.8M
  • IOVA 771.4M
  • IPO Year
  • NX N/A
  • IOVA N/A
  • Fundamental
  • Price
  • NX $20.51
  • IOVA $1.74
  • Analyst Decision
  • NX Strong Buy
  • IOVA Buy
  • Analyst Count
  • NX 1
  • IOVA 10
  • Target Price
  • NX $38.00
  • IOVA $12.22
  • AVG Volume (30 Days)
  • NX 580.4K
  • IOVA 11.7M
  • Earning Date
  • NX 09-04-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • NX 1.56%
  • IOVA N/A
  • EPS Growth
  • NX N/A
  • IOVA N/A
  • EPS
  • NX 0.39
  • IOVA N/A
  • Revenue
  • NX $1,625,028,000.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • NX $49.00
  • IOVA $86.62
  • Revenue Next Year
  • NX $2.99
  • IOVA $69.95
  • P/E Ratio
  • NX $52.20
  • IOVA N/A
  • Revenue Growth
  • NX 47.66
  • IOVA 11070.12
  • 52 Week Low
  • NX $15.30
  • IOVA $1.64
  • 52 Week High
  • NX $34.97
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • NX 62.34
  • IOVA 38.67
  • Support Level
  • NX $18.75
  • IOVA $1.67
  • Resistance Level
  • NX $19.66
  • IOVA $1.82
  • Average True Range (ATR)
  • NX 0.79
  • IOVA 0.12
  • MACD
  • NX 0.17
  • IOVA -0.00
  • Stochastic Oscillator
  • NX 75.84
  • IOVA 13.85

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: